Restoring Vaccine Diplomacy

“…Vaccines are also used as a form of humanitarian aid, giving rise to the phenomenon of vaccine diplomacy . 41 Prejudice toward or against a vaccine can introduce political biases into what should be an objective, transparent, scientific process. 39…”

“…The U.S. National Institutes of Health have also released numerous funding opportunities for research leading to a Ct vaccine. Yet, as identified earlier, lower patient and provider buy-in for vaccines against antibiotic-curable STIs remains a barrier to their production by high-income countries, whose concentration of manufacturers renders resource-poor countries lacking vaccine sovereignty 85 .…”

“…The WIV and protein-based vaccines offer enormous promise for filling the COVID-19 vaccine access gaps, especially for the world's LMICs in Africa, Latin America, and Southeast Asia. An attractive feature of these vaccines is their capacity for production in LMICs, especially the Developing Country Vaccine Manufacturer Network producers in Brazil, Cuba, Mexico, South Africa, China, India, Indonesia, and elsewhere (1). Vaccine producers will need to be responsible for manufacturing up to 6 billion doses of vaccine or more, considered a global priority for bringing the Southern Hemisphere up to the high vaccination rates already achieved in North America, Europe, and Israel (1).…”